此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)

2026年8月5日 更新者:Nathaphong Dejthida、DejthidaNathaphong

Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)

To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.

研究概览

详细说明

The study of the first degree, both sides in some of the aortic branch group, the effect and/or cause of systemic arterial hypertension compared to normotension. According to the theory of systemic arterial hypertension, the arterial resistance and high blood volume flow causing systemic arterial hypertension, the cause of arterial resistance and high blood volume flow evaluation may trace back to the possible actual cause of systemic arterial hypertension by backward investigation. Despite the fact that target organ damage is the crucial maneuver of hypertension evaluation, both sides of the common carotid artery, renal artery, and femoral artery may cause systemic arterial hypertension and may imply that feasible to predict the end organ of stroke, ESRD, and amputated-type arterial occlusion, respectively.

This study belongs to 2 questions

  1. Can the main aortic branch be evidence of a cause of systemic arterial hypertension following high resistance and/or high fluid flow by theory?
  2. Can the main aortic branch be a marker of evidence of endpoint organ damage?

研究类型

观察性的

注册 (估计的)

100

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Nathaphong Dejthida, Medical Degree
  • 电话号码:+66819220662
  • 邮箱:bnnatto@gmail.com

学习地点

    • Bangkok
      • Vadhana、Bangkok、泰国、10110
        • Invstigation center
        • 接触:
          • Nathaphong Dejthida, Medical Degree
          • 电话号码:0819220662
          • 邮箱:bnnatto@gmail.com

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

取样方法

非概率样本

研究人群

Hypertensive patient who underwent the radiographic measurement of structure and function of carotid artery, renal artery or femoral artery

描述

Inclusion Criteria:

  • Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants.
  • Imaging evidence of at least 1 list of

    • Common carotid artery
    • Renal artery
    • Femoral artery

Exclusion Criteria:

  • Fatal pathology and imaging
  • Pediatric or pregnant participants
  • Small vessel angiogram
  • Intravascular endoscopy
  • Intra-operative estimation

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Common Carotid Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Common Carotid Artery.
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery
Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)
Renal Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Renal Artery.
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery
Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)
Femoral Artery
The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Femoral Artery.
Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery
Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Median of diameter of common carotid artery, renal artery and femoral artery in hypertension patients.
大体时间:1 years
Radiographic measurement includes ultrasonography, CT/MR imaging, and intravascular contrast media imaging that measure the diameter in cm. unit of any side of common carotid artery and/or renal artery and/or femoral artery in hypertension patients.
1 years

次要结果测量

结果测量
措施说明
大体时间
Common Carotid Artery Function
大体时间:1 year
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Common Carotid Artery
1 year
Renal Artery Function
大体时间:1 year
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Renal Artery
1 year
Femoral Artery Function
大体时间:1 year
Any kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Femoral Artery
1 year

其他结果措施

结果测量
措施说明
大体时间
All-cause mortality outcomes
大体时间:1 year
Incidence of mortality rate (case per 1,000 person-year) of hypertensive participants were underwent measurement the diameter one side of one of common carotid artery and/or renal artery and/or femoral artery
1 year

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

有用的网址

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2026年12月31日

研究完成 (估计的)

2027年5月18日

研究注册日期

首次提交

2026年7月30日

首先提交符合 QC 标准的

2026年8月5日

首次发布 (实际的)

2026年8月12日

研究记录更新

最后更新发布 (实际的)

2026年8月12日

上次提交的符合 QC 标准的更新

2026年8月5日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅